dpp-4 inhibitor and glp-1 receptor agonist combination not recommended ada Differences between agonists inhibitors GLP-1 receptor agonist versus DPP-4

The abdomen (avoiding a 2-inch radius around the navel), outer thigh, and upper arm provide suitable injection locations with adequate subcutaneous tissue

GLP-1 RAs are considered to have a lower administration burden

Clinicians discussions revealed it as a complementary long-term option for immune health

We specialize in helping you get to the root cause and restore health and vitality with personalized functional medicine, hormone optimization, and restorative therapies

Breda PC, Wiech T, Meyer-Schwesinger C et al (2019) Renal proximal tubular epithelial cells exert immunomodulatory function by driving inflammatory CD4+ T cell responses